Symmetry Investments’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-12,400
Closed -$22.7K 162
2024
Q1
$22.7K Buy
+12,400
New +$22.7K ﹤0.01% 155